Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001493152-20-003043

Options or other derivatives

  • Director acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Stein Robert Benjamin Director 2020-02-21 Grant or award · PTIX Common stock Options +150,000 150,000 D: show line 1 in the form
Loading xslF345X03/ownership.xml…